One link includes mention of the upcoming trial that will combine ATL-DC, PLX3397 and pembrolizumab.
The link that mentions the trial was updated a couple months ago, so I would take that as current.
The trial has not yet been posted on ct.gov, so no idea when, or if, it runs. There are some trials running that combine pembrollizumab and PLX3397.